Terms: = Head and neck cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Treatment
170 results:
1. Three Artemisia pollens trigger the onset of allergic rhinitis via TLR4/MyD88 signaling pathway.
Zhang J; Gao L; Yu D; Song Y; Zhao Y; Feng Y
Mol Biol Rep; 2024 Feb; 51(1):319. PubMed ID: 38388914
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma.
Kuk SK; Kim K; Lee JI; Pang K
Sci Rep; 2024 Jan; 14(1):2427. PubMed ID: 38287071
[TBL] [Abstract] [Full Text] [Related]
3. NK cells propagate T cell immunity following in situ tumor vaccination.
Jin WJ; Jagodinsky JC; Vera JM; Clark PA; Zuleger CL; Erbe AK; Ong IM; Le T; Tetreault K; Berg T; Rakhmilevich AL; Kim K; Newton MA; Albertini MR; Sondel PM; Morris ZS
Cell Rep; 2023 Dec; 42(12):113556. PubMed ID: 38096050
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer.
Karbach J; Kiselicki D; Brand K; Wahle C; Sinelnikov E; Gustavus D; Hoffmeister H; Prisack HB; Atmaca A; Jäger E
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627144
[TBL] [Abstract] [Full Text] [Related]
5. EGF‑il2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models.
Qiu Y; Qi Z; Wang Z; Cao Y; Lu L; Zhang H; Mathes D; Pomfret EA; Lu SL; Wang Z
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36579667
[TBL] [Abstract] [Full Text] [Related]
6. Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines.
Lee J; Keam B; Park HR; Park JE; Kim S; Kim M; Kim TM; Kim DW; Heo DS
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5705-5715. PubMed ID: 36547689
[TBL] [Abstract] [Full Text] [Related]
7. The influence of thyroid hormone medication on intra-therapeutic half-life of
Happel C; Kranert WT; Bockisch B; Sabet A; Grünwald F; Groener D
Sci Rep; 2022 Aug; 12(1):13925. PubMed ID: 35978004
[TBL] [Abstract] [Full Text] [Related]
8. Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with
Hsieh YP; Wu YH; Cheng SM; Lin FK; Hwang DY; Jiang SS; Chen KC; Chen MY; Chiang WF; Liu KJ; Huynh NC; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563222
[TBL] [Abstract] [Full Text] [Related]
9. Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory head and neck cancer.
Clubb JHA; Kudling TV; Heiniö C; Basnet S; Pakola S; Cervera Carrascón V; Santos JM; Quixabeira DCA; Havunen R; Sorsa S; Zheng V; Salo T; Bäck L; Aro K; Tulokas S; Loimu V; Hemminki A
Front Immunol; 2022; 13():794251. PubMed ID: 35355980
[TBL] [Abstract] [Full Text] [Related]
10. B cells imprint adoptively transferred CD8
Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
[TBL] [Abstract] [Full Text] [Related]
11. Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival.
de Klerk LK; Patel AK; Derks S; Pectasides E; Augustin J; Uduman M; Raman N; Akarca FG; McCleary NJ; Cleary JM; Rubinson DA; Clark JW; Fitzpatrick B; Brais LK; Cavanaugh ME; Rode AJ; Jean MG; Lizotte PH; Nazzaro MJ; Severgnini M; Zheng H; Fuchs CS; Enzinger PC; Bass AJ
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593617
[TBL] [Abstract] [Full Text] [Related]
12. FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.
Bickett TE; Knitz M; Darragh LB; Bhatia S; Van Court B; Gadwa J; Bhuvane S; Piper M; Nguyen D; Tu H; Lenz L; Clambey ET; Barry K; Karam SD
Clin Cancer Res; 2021 Nov; 27(22):6235-6249. PubMed ID: 34518311
[TBL] [Abstract] [Full Text] [Related]
13. PD-1 blockade prevents the progression of oral carcinogenesis.
Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
[TBL] [Abstract] [Full Text] [Related]
14. Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review.
Diesch T; Filippi C; Fritschi N; Filippi A; Ritz N
Cytokine; 2021 Jul; 143():155506. PubMed ID: 33846070
[TBL] [Abstract] [Full Text] [Related]
15. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis.
Yuan X; Zhang AZ; Ren YL; Wang XL; Jiang CH; Yang L; Liu CX; Liang WH; Pang LJ; Gu WY; Li F; Hu JM
Medicine (Baltimore); 2021 Apr; 100(13):e24519. PubMed ID: 33787569
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of different regimens in nasal NK/T-cell lymphoma and analysis of serum inflammation and prognosis of patients.
Zhang L; Huang Y; Wang Y
J BUON; 2020; 25(4):1997-2002. PubMed ID: 33099944
[TBL] [Abstract] [Full Text] [Related]
17. CUE-101, a Novel E7-pHLA-il2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the treatment of HPV16-Driven Malignancies.
Quayle SN; Girgis N; Thapa DR; Merazga Z; Kemp MM; Histed A; Zhao F; Moreta M; Ruthardt P; Hulot S; Nelson A; Kraemer LD; Beal DR; Witt L; Ryabin J; Soriano J; Haydock M; Spaulding E; Ross JF; Kiener PA; Almo S; Chaparro R; Seidel R; Suri A; Cemerski S; Pienta KJ; Simcox ME
Clin Cancer Res; 2020 Apr; 26(8):1953-1964. PubMed ID: 31964784
[TBL] [Abstract] [Full Text] [Related]
18. Oncolytic activity of HF10 in head and neck squamous cell carcinomas.
Esaki S; Goshima F; Ozaki H; Takano G; Hatano Y; Kawakita D; Ijichi K; Watanabe T; Sato Y; Murata T; Iwata H; Shibamoto Y; Murakami S; Nishiyama Y; Kimura H
Cancer Gene Ther; 2020 Aug; 27(7-8):585-598. PubMed ID: 31477804
[TBL] [Abstract] [Full Text] [Related]
19. [
Chen S; Li Z; Zhou L; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):554-560. PubMed ID: 31140419
[TBL] [Abstract] [Full Text] [Related]
20. Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells.
Liu H; Zou M; Li P; Wang H; Lin X; Ye J
Mol Med Rep; 2019 May; 19(5):4081-4090. PubMed ID: 30896871
[TBL] [Abstract] [Full Text] [Related]
[Next]
